File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma

TitleDownregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma
Authors
Issue Date2014
PublisherOxford University Press. The Journal's web site is located at http://carcin.oxfordjournals.org/
Citation
Carcinogenesis, 2014, v. 35 n. 5, p. 1154-1161 How to Cite?
AbstractHere, we report the characterization of a candidate tumor suppressor gene leucine-rich glioma inactivated 1 (LGI1) in human esophageal squamous cell carcinoma (ESCC). Downregulation of LGI1 has been detected in approximately 50% of primary ESCCs, which was significantly associated with advanced clinical stage (P < 0.001), lymph node metastasis (P < 0.001), tumor invasion (P = 0.009) and poor disease-specific survival (P < 0.001). Functional studies found that LGI1 could inhibit cell growth, clonogenicity, cell motility and tumor formation in nude mice. Mechanistic investigations suggested that LGI1 acted through extracellular signal-regulated kinase (ERK1/2) signaling to downregulate matrix metalloproteinase (MMP)-3 expression and subsequently suppressed tumor metastasis. Taken together, our study revealed that LGI1 plays an important tumor suppressive role in the development and progression of ESCC, with possible application in clinics as a biomarker and a potential new therapeutic target.
Persistent Identifierhttp://hdl.handle.net/10722/198475
ISSN
2015 Impact Factor: 4.874
2015 SCImago Journal Rankings: 2.439
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorZhu, YH-
dc.contributor.authorLiu, H-
dc.contributor.authorSONG, Y-
dc.contributor.authorZHANG, LY-
dc.contributor.authorZeng, T-
dc.contributor.authorQin, YR-
dc.contributor.authorLi, L-
dc.contributor.authorLiu, L-
dc.contributor.authorLI, J-
dc.contributor.authorZhang, B-
dc.contributor.authorGuan, X-
dc.date.accessioned2014-07-07T07:08:31Z-
dc.date.available2014-07-07T07:08:31Z-
dc.date.issued2014-
dc.identifier.citationCarcinogenesis, 2014, v. 35 n. 5, p. 1154-1161-
dc.identifier.issn0143-3334-
dc.identifier.urihttp://hdl.handle.net/10722/198475-
dc.description.abstractHere, we report the characterization of a candidate tumor suppressor gene leucine-rich glioma inactivated 1 (LGI1) in human esophageal squamous cell carcinoma (ESCC). Downregulation of LGI1 has been detected in approximately 50% of primary ESCCs, which was significantly associated with advanced clinical stage (P < 0.001), lymph node metastasis (P < 0.001), tumor invasion (P = 0.009) and poor disease-specific survival (P < 0.001). Functional studies found that LGI1 could inhibit cell growth, clonogenicity, cell motility and tumor formation in nude mice. Mechanistic investigations suggested that LGI1 acted through extracellular signal-regulated kinase (ERK1/2) signaling to downregulate matrix metalloproteinase (MMP)-3 expression and subsequently suppressed tumor metastasis. Taken together, our study revealed that LGI1 plays an important tumor suppressive role in the development and progression of ESCC, with possible application in clinics as a biomarker and a potential new therapeutic target.-
dc.languageeng-
dc.publisherOxford University Press. The Journal's web site is located at http://carcin.oxfordjournals.org/-
dc.relation.ispartofCarcinogenesis-
dc.titleDownregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma-
dc.typeArticle-
dc.identifier.emailGuan, X: xyguan@hkucc.hku.hk-
dc.identifier.authorityGuan, X=rp00454-
dc.identifier.doi10.1093/carcin/bgu040-
dc.identifier.pmid24510112-
dc.identifier.scopuseid_2-s2.0-84901984673-
dc.identifier.hkuros229768-
dc.identifier.volume35-
dc.identifier.issue5-
dc.identifier.spage1154-
dc.identifier.epage1161-
dc.identifier.isiWOS:000336043800022-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats